BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20947489)

  • 1. A mouse model for human anal cancer.
    Stelzer MK; Pitot HC; Liem A; Schweizer J; Mahoney C; Lambert PF
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1534-41. PubMed ID: 20947489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
    Carchman EH; Matkowskyj KA; Meske L; Lambert PF
    PLoS One; 2016; 11(10):e0164273. PubMed ID: 27706233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant role of HPV16 E7 in anal carcinogenesis.
    Thomas MK; Pitot HC; Liem A; Lambert PF
    Virology; 2011 Dec; 421(2):114-8. PubMed ID: 21999991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits anal carcinogenesis in two preclinical animal models.
    Stelzer MK; Pitot HC; Liem A; Lee D; Kennedy GD; Lambert PF
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1542-51. PubMed ID: 21149330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
    Herber R; Liem A; Pitot H; Lambert PF
    J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
    Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
    Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer.
    Medeiros-Fonseca B; Mestre VF; Estêvão D; Sánchez DF; Cañete-Portillo S; Fernández-Nestosa MJ; Casaca F; Silva S; Brito H; Félix A; Medeiros R; Colaço B; Oliveira PA; Bastos MM; Nelson PS; Vakar-Lopez F; Gaivão I; Brito L; Lopes C; Cubilla AL; Gil da Costa RM
    J Pathol; 2020 Aug; 251(4):411-419. PubMed ID: 32488868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating Mutations in
    Shin MK; Payne S; Bilger A; Matkowskyj KA; Carchman E; Meyer DS; Bentires-Alj M; Deming DA; Lambert PF
    Clin Cancer Res; 2019 Mar; 25(6):1889-1900. PubMed ID: 30530704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
    Song S; Pitot HC; Lambert PF
    J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pocket proteins suppress head and neck cancer.
    Shin MK; Pitot HC; Lambert PF
    Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
    Buonomo T; Carraresi L; Rossini M; Martinelli R
    J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
    Jabbar S; Strati K; Shin MK; Pitot HC; Lambert PF
    Virology; 2010 Nov; 407(1):60-7. PubMed ID: 20797753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in breast tumorigenesis.
    Yasmeen A; Bismar TA; Dekhil H; Ricciardi R; Kassab A; Gambacorti-Passerini C; Al Moustafa AE
    Cell Cycle; 2007 Dec; 6(23):2939-43. PubMed ID: 18156804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
    Strati K; Pitot HC; Lambert PF
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.
    Song S; Liem A; Miller JA; Lambert PF
    Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes.
    Kang JK; Kim JH; Lee SH; Kim DH; Kim HS; Lee JE; Seo JS
    Cancer Lett; 2000 Nov; 160(2):177-83. PubMed ID: 11053647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
    Gunder LC; Johnson HR; Yao E; Moyer TH; Green HA; Sherer N; Zhang W; Carchman EH
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility.
    Sarkar J; Dominguez E; Li G; Kusewitt DF; Johnson DG
    Mol Carcinog; 2014 Aug; 53(8):648-58. PubMed ID: 23475592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
    Jung YS; Kato I; Kim HR
    Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.
    Simonson SJ; Difilippantonio MJ; Lambert PF
    Cancer Res; 2005 Sep; 65(18):8266-73. PubMed ID: 16166303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.